Purpose
To support the early-stage development and validation of Prema's thermostable cRNA-VLP vaccine platform with a specific focus on achieving durable immune responses suitable for low- and middle-income countries (LMICs).
Grantee
Division
Global Health
Date
AUGUST 2025
Region served
GLOBAL
Committed amount
$1,550,000
Grant topic
Vaccine Development
Duration (months)
18
Grantee location
Gurugram, Haryana, India
Related work
More about our financials
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.